Michael Böhm

Showing 1-13 of 13 articles

Review and meta-analysis of renal artery damage following percutaneous renal denervation with radiofrequency renal artery ablation

Townsend R, Walton A, Hettrick D, Hickey G, Weil J, Sharp A, Blankenstijn P, Böhm M, Mancia G

May 20, 2020 | 10.4244/EIJ-D-19-00902

Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial

Scheller B, Ohlow M, Ewen S, Kische S, Rudolph T, Clever Y, Wagner A, Richter S, El-Garhy M, Böhm M, Degenhardt R, Mahfoud F, Lauer B

April 17, 2020 | 10.4244/EIJ-D-19-00723

Other

Renal artery anatomy assessed by quantitative analysis of selective renal angiography in 1,000 patients with hypertension

Lauder L, Ewen S, Tzafriri A, Edelman E, Lüscher T, Blankestijn P, Dörr O, Schlaich M, Sharif F, Voskuil M, Zeller T, Ukena C, Scheller B, Böhm M, Mahfoud F

May 20, 2018 | 10.4244/EIJ-D-18-00112

TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY)

Lauten A, Figulla HR, Möllmann H, Holzhey D, Kotting J, Beckmann A, Veit C, Cremer J, Kuck K, Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Böhm M, Heusch G, Meinertz T, Neumann T, Welz A, Mohr F, Hamm C

November 20, 2014 | 10.4244/EIJV10I7A145

Anxiety, depression, quality of life and stress in patients with resistant hypertension before and after catheter-based renal sympathetic denervation

Lenski D, Kindermann I, Lenski M, Ukena C, Bunz M, Mahfoud F, Böhm M

October 25, 2013 | 10.4244/EIJV9I6A114

Rationale and design of a large registry on renal denervation: the Global SYMPLICITY registry

Böhm M, Mahfoud F, Ukena C, Bauer A, Fleck E, Hoppe U, Kintscher U, Narkiewicz K, Negoita M, Ruilope L, Rump L, Schlaich M, Schmieder R, Sievert H, Weil J, Williams B, Zeymer U, Mancia G

August 23, 2013 | 10.4244/EIJV9I4A78

Response and non-response to renal denervation: who is the ideal candidate?

Ukena C, Cremers B, Ewen S, Böhm M, Mahfoud F

May 21, 2013 | 10.4244/EIJV9SRA10

Potential role of renal sympathetic denervation for the treatment of cardiac arrhythmias

Ukena C, Mahfoud F, Linz D, Böhm M, Neuberger H-R

May 21, 2013 | 10.4244/EIJV9SRA19

Expanding the indication spectrum: renal denervation in diabetes

Mahfoud F, Ewen S, Ukena C, Linz D, Sobotka P, Cremers B, Böhm M

May 21, 2013 | 10.4244/EIJV9SRA20

Therapeutic potential of renal sympathetic denervation in patients with chronic heart failure

Böhm M, Ewen S, Linz D, Reil J-C, Schirmer S, Ukena C, Mahfoud F

May 21, 2013 | 10.4244/EIJV9SRA21

First-in-human experience: percutaneous renal denervation through a false lumen fenestration in aortic dissection type B

Ewen S, Mahfoud F, Böhm M

January 18, 2013 | 10.4244/EIJV8I9A170

Paclitaxel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study

Fischer D, Scheller B, Schäfer A, Klein G, Böhm M, Clever Y, Cremers B

August 24, 2012 | 10.4244/EIJV8I4A71

Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells

Clever Y, Cremers B, KrauÃŸ B, Böhm M, Speck U, Laufs U, Scheller B

May 17, 2011

1

Latest news

Focus on emerging physiology indices, TAVI, sizing with abnormal aortic cusps, a megaregistry of complex PCIs and more…

Tetralogy of Fallot with acquired double right ventricular outflow tract

September 18, 2020

Ahead of print: Leaflex Study

September 23, 2020

Integrating physiology in OCT

September 23, 2020

VOYAGER PAD, PARTNER 2A, ISCHEMIA and much more

(The Trials book is supported by Biotronik)

August 28, 2020

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Steady-state hyperaemia

September 18, 2020

This Week's JAA's: Biograde Study, Advances in valvular heart interventions...

September 22, 2020

Valvular disease